Apollo Hospitals Enterprise balance sheet

As of Mar 2026

Total assets: ₹22,197cr+7.5% on Mar 2025
Shareholders' equity: ₹9,975cr+15.3% on Mar 2025
Total debt: ₹5,659cr+7.3% on Mar 2025
Cash and investments: ₹1,828cr−9.1% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	11,039	9,816	8,541	7,432
	992	771	845	602
	2.2	2.8	3.4	4.1
	1,032	1,031	1,012	986
	199	139	108	97.8
	40.9	150	28.1	8.2
	256	224	198	186
	906	830	104	95.7
	15.6	27.2	6.6	8.4
	549	213	253	297
	1,471	1,070	363	401
	14.1	13.1	10.9	12.1
	252	412	365	362
	15,297	13,629	11,473	10,091
	542	481	460	390
	1,017	1,432	684	292
	3,485	3,016	2,515	2,234
	811	578	506	433
	306	782	428	342
	2.4	5.1	4.9	5.6
	737	182	166	294
	6,357	5,996	4,304	3,602
	342	552	516	345
	6,900	7,029	5,280	4,337
	22,197	20,657	16,753	14,428
Equity
	71.9	71.9	71.9	71.9
	9,408	8,140	6,864	6,125
	9,480	8,212	6,935	6,197
	494	441	385	334
	9,975	8,653	7,321	6,531
Liabilities
	2,430	4,417	2,236	1,938
	2,700	2,445	1,992	2,115
	5,130	6,862	4,227	4,052
	99.5	88.6	73.2	57.4
	498	458	450	442
	13.0	16.8	17.7	19.7
	5,741	7,426	4,768	4,572
	3,228	858	926	773
	2,252	2,241	2,369	1,916
	495	1,035	988	283
	5,975	4,134	4,283	2,972
	195	179	143	113
	2.6	1.6	1.3	2.8
	308	264	237	238
	6,481	4,579	4,665	3,325
	12,222	12,005	9,433	7,896
	22,197	20,657	16,753	14,428
Assets — additional as-filed lines
	0.0	0.0	242	210
Trade payables — MSME split
	123	80.8	84.8	53.7
	2,129	2,160	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

APOLLOHOSP₹8,200.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health

₹ CrorePeersFORTIS MAXHEALTH MEDANTA SUNPHARMA CIPLA DRREDDY DIVISLAB TORNTPHARMMcap ₹1.18L Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	7,432.1	8,540.5	9,815.7	11,038.6	11,038.6
+ Capital Work-in-Progress	601.7	844.7	771.0	991.5	991.5
+ Investment Property	4.1	3.4	2.8	2.2	2.2
+ Goodwill	985.8	1,012.3	1,030.5	1,032.3	1,032.3
+ Other Intangibles	97.8	107.7	139.2	198.5	198.5
+ Intangibles under Development	8.2	28.1	150.0	40.9	40.9
+ Investments (Equity Method)	185.8	198.4	224.1	256.4	256.4
+ Non-current Investments	95.7	103.7	830.4	905.8	905.8
+ Long-term Loans	8.4	6.6	27.2	15.6	15.6
+ Other Non-current Financial Assets	296.8	252.5	212.6	549.1	549.1
Non-current Financial Assets	400.9	362.8	1,070.2	1,470.5	1,470.5
+ Deferred Tax Assets	12.1	10.9	13.1	14.1	14.1
+ Other Non-current Assets	362.4	364.6	411.9	252.1	252.1
Total Non-current Assets	10,090.6	11,473.4	13,628.5	15,297.1	15,297.1
Current Assets
+ Inventories	390.2	459.8	480.8	542.4	542.4
+ Current Investments	292.2	684.0	1,432.3	1,016.5	1,016.5
+ Trade Receivables	2,234.2	2,514.9	3,016.1	3,484.9	3,484.9
+ Cash & Cash Equivalents	433.4	505.5	578.1	811.3	811.3
+ Other Bank Balances	342.4	428.3	782.1	305.5	305.5
+ Short-term Loans	5.6	4.9	5.1	2.4	2.4
+ Other Current Financial Assets	293.9	165.9	182.2	736.8	736.8
Current Financial Assets	3,601.8	4,303.5	5,995.9	6,357.4	6,357.4
+ Other Current Assets	345.2	516.4	552.2	342.0	342.0
Total Current Assets	4,337.2	5,279.7	7,028.9	6,899.8	6,899.8
Total Assets	14,427.7	16,753.1	20,657.4	22,196.9	22,196.9
Equity
+ Equity Share Capital	71.9	71.9	71.9	71.9	71.9
+ Other Equity / Reserves	6,125.3	6,863.5	8,140.4	9,408.2	9,408.2
Equity — Owners of Parent	6,197.1	6,935.4	8,212.3	9,480.1	9,480.1
+ Minority Interest	334.1	385.1	440.6	494.4	494.4
Total Equity	6,531.3	7,320.5	8,652.9	9,974.5	9,974.5
Liabilities
+ Borrowings — Non-current	1,937.6	2,235.6	4,417.0	2,430.1	2,430.1
+ Other Non-current Financial Liab	2,114.5	1,991.8	2,445.2	2,700.3	2,700.3
Non-current Financial Liabilities	4,052.1	4,227.4	6,862.2	5,130.4	5,130.4
+ Provisions — Non-current	57.4	73.2	88.6	99.5	99.5
+ Deferred Tax Liabilities	442.4	449.8	458.0	498.2	498.2
+ Other Non-current Liabilities	19.7	17.7	16.8	13.0	13.0
Non-current Liabilities	4,571.7	4,768.1	7,425.6	5,741.1	5,741.1
+ Borrowings — Current	772.7	926.3	858.2	3,228.4	3,228.4
+ Trade Payables	1,915.7	2,368.5	2,240.5	2,251.8	2,251.8
+ Other Current Financial Liab	283.3	988.1	1,035.0	495.1	495.1
Current Financial Liabilities	2,971.7	4,282.9	4,133.7	5,975.3	5,975.3
+ Provisions — Current	112.7	143.4	179.3	195.3	195.3
+ Current Tax Liabilities	2.8	1.3	1.6	2.6	2.6
+ Other Current Liabilities	237.7	236.9	264.3	308.1	308.1
Current Liabilities	3,324.8	4,664.5	4,578.9	6,481.3	6,481.3
Total Liabilities	7,896.5	9,432.6	12,004.5	12,222.4	12,222.4
Total Equity & Liabilities	14,427.7	16,753.1	20,657.4	22,196.9	22,196.9
Assets — additional as-filed lines
+ Current Tax Assets	209.5	242.4	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	53.7	84.8	80.8	122.6	122.6
+ Dues to Other Creditors — Current	—	—	2,159.7	2,129.2	2,129.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.